RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl
5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
2008-01-01 Maurillo, L; Spagnoli, A; Gozzini, A; Cecconi, N; 2 D'Argenio, M; Lunghi, M; Rocco, S; Palumbo, G; Rivellini, F; Genuardi, M; Sibilla, S; Ferrara, F; Mele, G; Filardi, N; Sanpaolo, G; Specchia, G; Tonso, A; Santagostino, A; Voso, Mt; Balleari, E; Cassibba, B; Della Cioppa, P; Mazzone, C; Oliva, E; Ciuffreda, L; Russo, D; Galimberti, Sara; Villani, O; D'Auria, F; Di Renzo, N; D'Arco, Am
5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES : RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
2008-01-01 Mustop, ; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, F; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, D; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, A; Tonso, A; Santagostino A., Villani O; D'Auria, F; D'Arco, A; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V.
5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
2008-01-01 Musto, P; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, C; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, P; Candoni, A; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, D; Tonso, A; Santagostino, A; Rocco, S; Villani, O; D’Auria, F; D’Arco, Am; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V.
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group
2008-01-01 Carella, Am; Nati, S; Fraternali Orcioni, G; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, P. L.
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA
2016-01-01 Drandi, D.; Genuardi, E; Dogliotti, I.; Sciascia, I.; Guerrini, Francesca; Mantoan, B.; Gilestro, M.; Muccio, V.; Ghione, P.; Omede, P.; Galimberti, Sara; Orsucci, L.; Cavallo, F.; Boccadoro, M.; Ladetto, M; Ferrero, S.
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL.
2012-01-01 Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
ACCURACY AND PRECISION OF RESULTS AFTER IMPLEMENTATION OF INTERNATIONAL SCALE TO EVALUATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA PATIENTS COORDINATED ON BEHALF OF GIMEMA-CML WP
2009-01-01 Quarantelli, F; Izzo, B; Amabile, M; Gottardi, E; Albano, F; Spinelli, O; Vigneri, P; Gozzini, A; Garuti, A; Pezzetti, L; Colnaghi, F; Monne, M; Santoro, A; Bernasconi, P; Di Ianni, M; Donati, M; Giannini, B; Mammi’, C; Diverio, D; Divona M., D; De Matteis, G; Rossi, G; Culurgioni, F; Minervini, M; Galimberti, Sara; Nicci, C; Saglio, G; Martinelli, G; Pane, F.
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases
2007-01-01 Focosi, D; Galimberti, Sara; Petrini, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl | |
(90)y lbritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S.; Orcioni, Gf; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, Pl | |
5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM | 1-gen-2008 | Maurillo, L; Spagnoli, A; Gozzini, A; Cecconi, N; 2 D'Argenio, M; Lunghi, M; Rocco, S; Palumbo, G; Rivellini, F; Genuardi, M; Sibilla, S; Ferrara, F; Mele, G; Filardi, N; Sanpaolo, G; Specchia, G; Tonso, A; Santagostino, A; Voso, Mt; Balleari, E; Cassibba, B; Della Cioppa, P; Mazzone, C; Oliva, E; Ciuffreda, L; Russo, D; Galimberti, Sara; Villani, O; D'Auria, F; Di Renzo, N; D'Arco, Am | |
5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES : RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM | 1-gen-2008 | Mustop, ; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, F; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, D; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, A; Tonso, A; Santagostino A., Villani O; D'Auria, F; D'Arco, A; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V. | |
5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program | 1-gen-2008 | Musto, P; Maurillo, L; Spagnoli, A; Gozzini, A; Rivellini, F; Tatarelli, C; Lunghi, M; Fili, C; Orciuolo, E; Ciuffreda, L; Vigna, E; Della Cioppa, P; Candoni, A; Ferrero, D; Palmieri, S; Palumbo, G; Di Renzo, N; Oliva, E; Sanpaolo, G; Pastore, D; Tonso, A; Santagostino, A; Rocco, S; Villani, O; D’Auria, F; D’Arco, Am; Gaidano, G; Galimberti, Sara; Russo, D; Venditti, A; Aloe Spiriti, Ma; Leone, G; Santini, V. | |
90y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group | 1-gen-2008 | Carella, Am; Nati, S; Fraternali Orcioni, G; Petrini, Mario; Galimberti, Sara; Vitolo, U; Cascavilla, N; Zinzani, P. L. | |
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA | 1-gen-2016 | Drandi, D.; Genuardi, E; Dogliotti, I.; Sciascia, I.; Guerrini, Francesca; Mantoan, B.; Gilestro, M.; Muccio, V.; Ghione, P.; Omede, P.; Galimberti, Sara; Orsucci, L.; Cavallo, F.; Boccadoro, M.; Ladetto, M; Ferrero, S. | |
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. | 1-gen-2012 | Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello | |
ACCURACY AND PRECISION OF RESULTS AFTER IMPLEMENTATION OF INTERNATIONAL SCALE TO EVALUATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA PATIENTS COORDINATED ON BEHALF OF GIMEMA-CML WP | 1-gen-2009 | Quarantelli, F; Izzo, B; Amabile, M; Gottardi, E; Albano, F; Spinelli, O; Vigneri, P; Gozzini, A; Garuti, A; Pezzetti, L; Colnaghi, F; Monne, M; Santoro, A; Bernasconi, P; Di Ianni, M; Donati, M; Giannini, B; Mammi’, C; Diverio, D; Divona M., D; De Matteis, G; Rossi, G; Culurgioni, F; Minervini, M; Galimberti, Sara; Nicci, C; Saglio, G; Martinelli, G; Pane, F. | |
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases | 1-gen-2007 | Focosi, D; Galimberti, Sara; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 130
- 1 Contributo su Rivista::1.5 Abst... 130
Data di pubblicazione
- 2010 - 2020 66
- 2000 - 2009 63
- 1996 - 1999 1
Rivista
- HAEMATOLOGICA 51
- BLOOD 45
- BONE MARROW TRANSPLANTATION 14
- HAEMATOLOGICA 8
- ANNALS OF THE RHEUMATIC DISEASES 3
- AMERICAN JOURNAL OF CLINICAL ONCO... 2
- BLOOD REVIEWS 2
- BONE MARROW TRANSPLANTATION 2
- ARTHRITIS AND RHEUMATISM 1
- LEUKEMIA RESEARCH 1
Keyword
- immune reconstitution 2
- immunotherapy 2
- T-lymphocytes 2
- AL-T 1
- ALL-T 1
- allogeneic stem cell transplant 1
- allogeneic stem cell transplantation 1
- allogeneic transplant 1
- Chronic Myeloid Leukemia 1
- immune surveillance 1
Lingua
- eng 79
Accesso al fulltext
- no fulltext 122
- open 5
- restricted 3